Reply to: "Performance status in patients with HCC: New kid on the block"

Affiliations

¹ I. Department of Internal Medicine, University Medical Centre of the Johannes Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany.
² I. Department of Internal Medicine, University Medical Centre of the Johannes Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany. Electronic address: galle@uni-mainz.de.

Comment

Marcus-Alexander Wörns et al. J Hepatol. 2017 Dec.

. 2017 Dec;67(6):1353-1355.

doi: 10.1016/j.jhep.2017.07.029. Epub 2017 Aug 10.

¹ I. Department of Internal Medicine, University Medical Centre of the Johannes Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany.
² I. Department of Internal Medicine, University Medical Centre of the Johannes Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany. Electronic address: galle@uni-mainz.de.

No abstract available

Comment on

The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy.
Galle PR, Tovoli F, Foerster F, Wörns MA, Cucchetti A, Bolondi L. Galle PR, et al. J Hepatol. 2017 Jul;67(1):173-183. doi: 10.1016/j.jhep.2017.03.007. Epub 2017 Mar 18. J Hepatol. 2017. PMID: 28323121 Review.
Performance status in patients with HCC: New kid on the block.
Huo TI, Hsu CY, Liu PH. Huo TI, et al. J Hepatol. 2017 Dec;67(6):1352-1353. doi: 10.1016/j.jhep.2017.06.036. Epub 2017 Aug 10. J Hepatol. 2017. PMID: 28803954 No abstract available.